Real-time Intervention for Suicide Risk Reduction

Sponsor
Massachusetts General Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05848089
Collaborator
Rutgers University (Other), National Institute of Mental Health (NIMH) (NIH)
50
2
15

Study Details

Study Description

Brief Summary

The aim of this study is to determine whether learning three skills for managing negative emotions and receiving reminders via smartphone to practice these skills reduces how often and how intensely one experiences emotional distress and suicidal thoughts.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Brief skills sessions plus EMI skills practice prompts
  • Behavioral: Ecological momentary assessment (EMA)
  • Behavioral: Treatment as usual (TAU)
N/A

Detailed Description

The present study is a two-arm parallel design RCT to test the efficacy of using ecological momentary intervention (EMI) to deliver therapeutic content based on the Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders (UP) - an evidence-based transdiagnostic cognitive behavioral therapy (CBT) that focuses on delivering adaptive skills for managing strong emotions. Participants in this study will be 50 adult psychiatric inpatients with recent suicidal thoughts or behaviors (STBs). Participants will be randomized to receive either the control condition, which consists of treatment as usual (TAU; n = 25) and 4x/daily daily ecological momentary assessment (EMA) of emotions and STBs, or the experimental condition, consisting of TAU, 4x/daily EMA, 3 brief sessions to deliver CBT skills (mindful emotion awareness, cognitive flexibility, and changing emotional behaviors, all drawn from the UP), one discretionary skills booster session, and EMI to prompt guided skills practice (n = 25).

Control participants will receive TAU and be prompted to complete 4x/day EMA of emotions and STBs for the duration of their hospital stay and the 28-day post-discharge period. Participants randomized to the experimental conditions will receive TAU plus three brief treatment sessions delivering core UP skills content (during inpatient stays) and a discretionary booster session to reinforce treatment sessions that may be offered after discharge via either phone or telehealth. Those in the experimental condition will also receive training to use the EMI (which prompts guided skills practice), followed by smartphone-based EMA/EMI for the duration of the inpatient stay and the 28-day post-discharge period.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Real-time Intervention for Suicide Risk Reduction
Anticipated Study Start Date :
Jul 1, 2023
Anticipated Primary Completion Date :
Oct 1, 2024
Anticipated Study Completion Date :
Oct 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Other: Treatment as usual (TAU) + EMA

Participants will receive TAU and be prompted to complete 4x/day smartphone-based EMA surveys of negative emotion and STBs.

Behavioral: Ecological momentary assessment (EMA)
4x/day brief smartphone-based EMA surveys assessing negative emotions and STBs

Behavioral: Treatment as usual (TAU)
TAU (or usual care) during hospitalization and the 28-day post-discharge period

Experimental: Experimental intervention + TAU

Participants will receive TAU plus 3 brief sessions of CBT skills, one discretionary post-discharge skills booster session, and 4x/day EMA and prompted EMI, which guides in-the-moment CBT skills practice.

Behavioral: Brief skills sessions plus EMI skills practice prompts
(1) Three brief treatment sessions delivering core cognitive behavioral therapy (CBT) skills (mindful emotion awareness, cognitive flexibility, and changing emotional behaviors) (during hospitalization), (2) a discretionary booster session to reinforce treatment session content (that may be offered after discharge via either phone or telehealth), and (3) ecological momentary intervention (EMI) prompts to engage in guided skills practice exercises via smartphone
Other Names:
  • cognitive behavioral therapy
  • ecological momentary intervention
  • Behavioral: Ecological momentary assessment (EMA)
    4x/day brief smartphone-based EMA surveys assessing negative emotions and STBs

    Behavioral: Treatment as usual (TAU)
    TAU (or usual care) during hospitalization and the 28-day post-discharge period

    Outcome Measures

    Primary Outcome Measures

    1. Within-person changes in momentary self-reported intensity of suicidal urges (measured on a 11-point rating scale via ecological momentary assessment) from pre- to post-EMI [Through study completion (up to 28 days after inpatient hospital discharge)]

      Overall changes in momentary self-reported intensity of suicidal urges (measured on a 11-point rating scale up to 4x/day via ecological momentary assessment) from pre- to post-EMI use, among those in the experimental condition only

    2. Between-condition differences in momentary self-reported intensity of suicidal urges (measured on a 11-point rating scale via ecological momentary assessment) [Through study completion (up to 28 days after inpatient hospital discharge)]

      Means and slopes of momentary self-reported intensity of suicidal urges (measured on a 11-point rating scale up to 4x/day via ecological momentary assessment) will be compared between the experimental and control conditions

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • adult status (18+ years),

    • a recent suicide attempt or any report of current suicidal ideation,

    • the ability to speak and write English fluently,

    • ownership of and consistent access to an internet-capable smartphone (e.g., an iPhone or Android phone), and

    • providing at least one collateral contact in cases where we cannot reach the participant

    Exclusion criteria:
    • the presence of any factor that impairs an individual's ability to provide informed consent and comprehend and effectively participate in the study including: an inability to speak or write English fluently, the presence of gross cognitive impairment due to florid psychosis, intellectual disability, dementia, acute intoxication, or the presence of extremely agitated or violent behavior.

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Massachusetts General Hospital
    • Rutgers University
    • National Institute of Mental Health (NIMH)

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Kate Bentley, PhD, Assistant Professor, Massachusetts General Hospital
    ClinicalTrials.gov Identifier:
    NCT05848089
    Other Study ID Numbers:
    • 2023P000221
    First Posted:
    May 8, 2023
    Last Update Posted:
    May 8, 2023
    Last Verified:
    Apr 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Kate Bentley, PhD, Assistant Professor, Massachusetts General Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 8, 2023